CVE:NXG NexgenRx (NXG) Stock Price, News & Analysis C$0.66 +0.11 (+20.00%) As of 03:55 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About NexgenRx Stock (CVE:NXG) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get NexgenRx alerts:Sign Up Key Stats Today's RangeC$0.56▼C$0.7550-Day RangeC$0.34▼C$0.5552-Week RangeC$0.29▼C$0.75Volume86,597 shsAverage Volume63,553 shsMarket CapitalizationC$46.94 millionP/E Ratio27.50Dividend Yield2.27%Price TargetN/AConsensus RatingN/A Company Overview NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada. Read More Receive NXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NXG Stock News HeadlinesNexgenRx Announces Solid Q1 2026 Results with Continued Increasing Revenue, Net Income and EBITDA GrowthMay 22, 2026 | theglobeandmail.comHere's Why We Think NexgenRx (CVE:NXG) Might Deserve Your Attention TodayApril 28, 2026 | finance.yahoo.comBuy this stock tomorrowMarc Chaikin, founder of Chaikin Analytics, is flagging a little-known company that just secured a partnership with Nvidia - one he believes positions it ahead of Tesla in the autonomous vehicle race. With a market-moving announcement expected on July 31st, Chaikin is urging investors to swap overpriced AI stocks for this under-the-radar name before markets open. He's also releasing a free Hotlist and Hitlist of buy and sell ideas for the second half of 2026.July 20 at 1:00 AM | Chaikin Analytics (Ad)NexgenRx Announces Declaration of DivdendsDecember 10, 2025 | finance.yahoo.comNexgenRx Reports Strong Q3 2025 Financial GrowthNovember 21, 2025 | msn.comMarket-beating micro-cap NexgenRX excels in Q3November 21, 2025 | msn.comIs NexgenRx Inc.'s (CVE:NXG) Recent Stock Performance Influenced By Its Financials In Any Way?October 13, 2025 | finance.yahoo.comNexgenRx Announces Second Quarter Results with Significant Revenue Growth and Positive EBITDAAugust 12, 2025 | theglobeandmail.comSee More Headlines NXG Stock Analysis - Frequently Asked Questions How have NXG shares performed this year? NexgenRx's stock was trading at C$0.40 at the start of the year. Since then, NXG stock has increased by 87.5% and is now trading at C$0.75. How do I buy shares of NexgenRx? Shares of NXG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of NexgenRx own? Based on aggregate information from My MarketBeat watchlists, some other companies that NexgenRx investors own include Vision Marine Technologies (VMAR), Hydro One (H) and Carvana (CVNA). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Healthcare Plans Sub-IndustryN/A Current SymbolCVE:NXG CIKN/A Webwww.nexgenrx.com Phone+1-416-6953393FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C$0.02 Trailing P/E Ratio27.50 Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$3.06 million Net Margins-0.17% Pretax MarginN/A Return on Equity-0.31% Return on Assets0.42% Debt Debt-to-Equity Ratio6.16 Current Ratio1.08 Quick Ratio0.12 Sales & Book Value Annual SalesC$18.45 million Price / Sales2.54 Cash FlowC$0.07 per share Price / Cash Flow9.64 Book ValueC$0.09 per share Price / Book7.33Miscellaneous Outstanding Shares71,117,000Free FloatN/AMarket CapC$46.94 million OptionableNot Optionable Beta0.45 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (CVE:NXG) was last updated on 7/20/2026 by MarketBeat.com Staff. From Our PartnersMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredI found Rolls-Royce at $2 - now I see the same setup againIn 2022, Karim Rahemtulla recommended Rolls-Royce under $2 - a misunderstood aerospace name the market had wri...Monument Traders Alliance | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored#1 Power Grid Stock Right NowThe U.S. power grid is cracking - and one company's technology is already generating round-the-clock power in ...Altimetry | SponsoredYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...SmartAsset | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexgenRx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexgenRx With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
